US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tourmaline Bio

47.98

0.0000

Volume:- -

Turnover:37.61M

Market Cap:1.24B

PE:-13.97

High:47.98

Open:47.98

Low:47.98

Close:47.98

52wk High:48.27

52wk Low:11.56

Shares:25.76M

Float Shares:13.12M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4351

EPS(LYR):-2.8882

ROE:-29.62%

ROA:-20.85%

PB:4.77

PE(LYR):-16.61

Loading ...

Overview Company News Filings

Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

Premarket Movers | Tourmaline Bio Soars 57%; Teck Resources Surges 8%; CoreWeave Jumps 7%; Alibaba Gains 3%; Planet Labs Sinks 14%

Tiger Newspress

Swiss stocks - Factors to watch on September 9

Novartis to Acquire Tourmaline Bio in Deal Valuing It at $1.4 Billion

BRIEF-Novartis To Buy Tourmaline Bio

Tourmaline Bio Inc - Novartis to Buy Tourmaline for $48 per Share, $1.4 Bln Equity Value

THOMSON REUTERS

Tourmaline Bio Enters Into Agreement to Be Acquired by Novartis Ag

THOMSON REUTERS

Tourmaline Bio Inc - Deal Expected to Complete in Q4 2025

THOMSON REUTERS

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

Tourmaline Bio Unveils Promising Phase 2 Trial Data for Pacibekitug at European Society of Cardiology Congress 2025

Tourmaline Bio Presents Data From the Ongoing Phase 2 Tranquility Trial at the 2025 European Society of Cardiology Congress

THOMSON REUTERS

Tourmaline Bio Is Maintained at Buy by Chardan Capital

Wedbush Adjusts Price Target on Tourmaline Bio to $48 From $43, Maintains Outperform Rating

MT Newswires Live

Tourmaline Bio Inc reports results for the quarter ended June 30 - Earnings Summary

Tourmaline Bio Q2 EPS $(0.90) Beats $(0.94) Estimate

Tourmaline Bio : on Track to Initiate Phase 2 Proof-of-Concept Trial in Abdominal Aortic Aneurysm in H2 2025

THOMSON REUTERS

Tourmaline Bio Inc: Cash, Cash Equivalents, and Investments as of June 30 Provide Expected Cash Runway Into Second Half of 2027

THOMSON REUTERS

Tourmaline Bio Inc: Qtrly Shr Loss $0.90

THOMSON REUTERS

Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Tourmaline Bio Inc expected to post a loss of 94 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TRML/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRML","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRML\",,,,,undefined,":{"symbol":"TRML","market":"US","secType":"STK","nameCN":"Tourmaline Bio","latestPrice":47.98,"timestamp":1761595200000,"preClose":47.98,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":13117896,"shares":25756021,"eps":-3.435149,"marketStatus":"Halted","change":0,"latestTime":"03-17 09:55:44 EDT","open":47.98,"high":47.98,"low":47.98,"amount":37610405.646589994,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.435149,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773777600000},"marketStatusCode":2,"adr":0,"listingDate":1620360000000,"exchange":"NASDAQ","adjPreClose":47.98,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRML\",,,,,undefined,":{"symbol":"TRML","floatShares":13117896,"roa":"-20.85%","roe":"-29.62%","lyrEps":-2.888196,"shares":25756021,"dividePrice":0,"high":47.98,"amplitude":0,"preClose":47.98,"low":47.98,"week52Low":11.56,"pbRate":"4.77","week52High":48.27,"institutionHeld":0,"latestPrice":47.98,"eps":-3.435149,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.435149,"open":47.98,"prevYearClose":20.28,"prevWeekClose":47.98,"prevMonthClose":47.83,"prevQuarterClose":47.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRML\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-29","symbol":"TRML","reason":null,"defaultRemindTime":1761744600000,"announcedDate":"2025-10-23","type":"delisting","dateTimestamp":1761710400000},{"market":"US","date":"2025-08-13","symbol":"TRML","fiscalQuarterEnding":"2025/06","expectedEps":-0.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-05-02","symbol":"TRML","fiscalQuarterEnding":"2025/03","expectedEps":-0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746158400000,"reportTimeType":"pre","actualEps":-0.89},{"market":"US","date":"2025-03-13","symbol":"TRML","fiscalQuarterEnding":"2024/12","expectedEps":-0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2024-11-07","symbol":"TRML","fiscalQuarterEnding":"2024/09","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRML\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRML\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.125,"hold":0.875,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.875,"analysts":8,"updateTime":1757908800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRML\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRML","date":"2025-10-27","current":-13.967371,"percent":0.164583,"low":-34.281816,"twenty":-13.942291,"median":-8.76739,"eighty":-5.922279,"high":-4.245235,"avg":-10.78598,"sd":6.39171,"marketCap":1237843696},"quantilePoints":[{"date":"2023-10-27","current":-8.71976,"twenty":-8.71976,"median":-8.71976,"eighty":-8.71976,"marketCap":266004990},{"date":"2023-11-03","current":-11.48635,"twenty":-11.479684,"median":-10.446378,"eighty":-9.333076,"marketCap":350402598},{"date":"2023-11-10","current":-10.793036,"twenty":-11.186358,"median":-10.579708,"eighty":-9.899727,"marketCap":329252354},{"date":"2023-11-17","current":-10.986364,"twenty":-10.99303,"median":-10.829702,"eighty":-10.326382,"marketCap":335150019},{"date":"2023-11-24","current":-11.615227,"twenty":-11.031696,"median":-10.76637,"eighty":-10.248203,"marketCap":396567073},{"date":"2023-12-01","current":-11.168487,"twenty":-11.229245,"median":-10.866367,"eighty":-10.342382,"marketCap":381314493},{"date":"2023-12-08","current":-10.870661,"twenty":-11.3174,"median":-10.953031,"eighty":-10.4513,"marketCap":371146107},{"date":"2023-12-15","current":-11.376966,"twenty":-11.3174,"median":-10.971922,"eighty":-10.506121,"marketCap":388432364},{"date":"2023-12-22","current":-11.990488,"twenty":-11.334079,"median":-11.000345,"eighty":-10.56642,"marketCap":409379240},{"date":"2023-12-29","current":-16.463839,"twenty":-11.448127,"median":-11.049357,"eighty":-10.624611,"marketCap":562108405},{"date":"2024-01-05","current":-15.832448,"twenty":-11.615227,"median":-11.12977,"eighty":-10.691965,"marketCap":540551426},{"date":"2024-01-12","current":-17.86958,"twenty":-14.057403,"median":-11.275705,"eighty":-10.739704,"marketCap":610103190},{"date":"2024-01-19","current":-18.042319,"twenty":-15.794326,"median":-11.3174,"eighty":-10.78237,"marketCap":616000854},{"date":"2024-01-26","current":-28.247663,"twenty":-17.245336,"median":-11.3174,"eighty":-10.802718,"marketCap":964431710},{"date":"2024-02-02","current":-25.696339,"twenty":-18.466423,"median":-11.376966,"eighty":-10.854121,"marketCap":877324413},{"date":"2024-02-09","current":-27.221144,"twenty":-19.414702,"median":-11.483017,"eighty":-10.869802,"marketCap":929384294},{"date":"2024-02-16","current":-29.594731,"twenty":-25.820542,"median":-11.615227,"eighty":-10.931224,"marketCap":1010423322},{"date":"2024-02-23","current":-27.386394,"twenty":-26.713376,"median":-11.990488,"eighty":-10.954365,"marketCap":935026252},{"date":"2024-03-01","current":-29.159073,"twenty":-27.368366,"median":-15.618013,"eighty":-10.967032,"marketCap":995549070},{"date":"2024-03-08","current":-31.036911,"twenty":-27.583191,"median":-15.832448,"eighty":-10.980587,"marketCap":1059662225},{"date":"2024-03-15","current":-31.337365,"twenty":-27.849093,"median":-16.776557,"eighty":-10.990364,"marketCap":1069920330},{"date":"2024-03-22","current":-17.418731,"twenty":-27.849093,"median":-17.86958,"eighty":-11.001809,"marketCap":733746622},{"date":"2024-03-28","current":-13.942291,"twenty":-27.737925,"median":-17.089275,"eighty":-11.024339,"marketCap":587305056},{"date":"2024-04-05","current":-13.369987,"twenty":-27.649291,"median":-16.097513,"eighty":-11.066035,"marketCap":563197337},{"date":"2024-04-12","current":-12.237556,"twenty":-27.601219,"median":-15.641839,"eighty":-11.122026,"marketCap":515494830},{"date":"2024-04-19","current":-9.534335,"twenty":-27.587698,"median":-14.761172,"eighty":-11.024339,"marketCap":401624330},{"date":"2024-04-26","current":-9.741339,"twenty":-27.562159,"median":-14.331944,"eighty":-10.964588,"marketCap":410344144},{"date":"2024-05-03","current":-9.692632,"twenty":-27.499064,"median":-13.999847,"eighty":-10.868085,"marketCap":408292423},{"date":"2024-05-10","current":-9.601307,"twenty":-27.413435,"median":-13.936202,"eighty":-10.711061,"marketCap":404445446},{"date":"2024-05-17","current":-8.025737,"twenty":-27.374376,"median":-13.351722,"eighty":-10.398841,"marketCap":384697635},{"date":"2024-05-24","current":-7.308771,"twenty":-27.302266,"median":-12.267998,"eighty":-9.914031,"marketCap":350331312},{"date":"2024-05-31","current":-7.233864,"twenty":-27.215971,"median":-12.121878,"eighty":-9.653666,"marketCap":346740801},{"date":"2024-06-07","current":-7.255266,"twenty":-27.185428,"median":-11.76414,"eighty":-9.572083,"marketCap":347766662},{"date":"2024-06-14","current":-8.881815,"twenty":-27.14603,"median":-11.588489,"eighty":-9.467363,"marketCap":425732049},{"date":"2024-06-21","current":-8.084592,"twenty":-27.109976,"median":-11.483017,"eighty":-9.430834,"marketCap":387518750},{"date":"2024-06-28","current":-7.0787,"twenty":-26.971767,"median":-11.440238,"eighty":-9.386998,"marketCap":339303314},{"date":"2024-07-05","current":-6.86468,"twenty":-26.454986,"median":-11.350161,"eighty":-9.074433,"marketCap":329044710},{"date":"2024-07-12","current":-7.597697,"twenty":-26.409918,"median":-11.3174,"eighty":-8.662445,"marketCap":364180427},{"date":"2024-07-15","current":-7.977582,"twenty":-26.391406,"median":-11.3174,"eighty":-8.3885,"marketCap":382389449},{"date":"2024-08-02","current":-8.742702,"twenty":-26.372893,"median":-11.3174,"eighty":-8.456986,"marketCap":419063957},{"date":"2024-08-09","current":-7.563763,"twenty":-26.068949,"median":-11.287618,"eighty":-8.103854,"marketCap":372825418},{"date":"2024-08-16","current":-7.111185,"twenty":-25.449967,"median":-11.168487,"eighty":-7.996844,"marketCap":350517432},{"date":"2024-08-23","current":-7.407701,"twenty":-24.869472,"median":-11.028509,"eighty":-7.771053,"marketCap":365133009},{"date":"2024-08-30","current":-8.968313,"twenty":-24.475141,"median":-10.986364,"eighty":-7.803156,"marketCap":442057098},{"date":"2024-09-06","current":-8.32326,"twenty":-24.06836,"median":-10.959698,"eighty":-7.825628,"marketCap":410261808},{"date":"2024-09-13","current":-9.264829,"twenty":-22.445383,"median":-10.872215,"eighty":-7.866292,"marketCap":456672675},{"date":"2024-09-20","current":-11.756605,"twenty":-20.29746,"median":-10.870661,"eighty":-7.979091,"marketCap":579494803},{"date":"2024-09-27","current":-12.927063,"twenty":-19.046589,"median":-10.935322,"eighty":-7.99325,"marketCap":637187870},{"date":"2024-10-04","current":-13.655348,"twenty":-18.735659,"median":-10.971922,"eighty":-8.030017,"marketCap":673085778},{"date":"2024-10-11","current":-14.295199,"twenty":-18.642737,"median":-11.000345,"eighty":-8.047139,"marketCap":704624655},{"date":"2024-10-18","current":-15.153535,"twenty":-18.505737,"median":-11.091052,"eighty":-8.05463,"marketCap":746932904},{"date":"2024-10-25","current":-14.22237,"twenty":-18.394945,"median":-11.231032,"eighty":-8.094223,"marketCap":701034864},{"date":"2024-10-31","current":-13.774995,"twenty":-18.161449,"median":-11.308466,"eighty":-8.132746,"marketCap":678983292},{"date":"2024-11-08","current":-11.103216,"twenty":-18.042319,"median":-11.3174,"eighty":-8.159499,"marketCap":709240100},{"date":"2024-11-15","current":-10.790634,"twenty":-17.86958,"median":-11.3174,"eighty":-8.214017,"marketCap":689273356},{"date":"2024-11-22","current":-9.120655,"twenty":-17.418731,"median":-11.275705,"eighty":-8.320014,"marketCap":582600099},{"date":"2024-11-29","current":-10.453427,"twenty":-17.155166,"median":-11.168487,"eighty":-8.322611,"marketCap":667733564},{"date":"2024-12-06","current":-9.646538,"twenty":-16.588926,"median":-11.070204,"eighty":-8.356553,"marketCap":616191918},{"date":"2024-12-13","current":-9.040368,"twenty":-16.38283,"median":-10.99303,"eighty":-8.47724,"marketCap":577471577},{"date":"2024-12-20","current":-8.165235,"twenty":-15.938474,"median":-10.96581,"eighty":-8.356553,"marketCap":521570687},{"date":"2024-12-27","current":-8.76739,"twenty":-15.803856,"median":-10.935322,"eighty":-8.34823,"marketCap":560034602},{"date":"2025-01-03","current":-8.285666,"twenty":-15.727613,"median":-10.872215,"eighty":-8.294497,"marketCap":529263470},{"date":"2025-01-10","current":-8.028746,"twenty":-15.632309,"median":-10.835753,"eighty":-8.286469,"marketCap":512852200},{"date":"2025-01-17","current":-6.956908,"twenty":-15.506057,"median":-10.790634,"eighty":-8.144818,"marketCap":444386431},{"date":"2025-01-24","current":-7.029167,"twenty":-15.153535,"median":-10.691965,"eighty":-8.084592,"marketCap":449002101},{"date":"2025-01-31","current":-6.583572,"twenty":-15.019926,"median":-10.527506,"eighty":-8.028746,"marketCap":420538804},{"date":"2025-02-07","current":-6.017545,"twenty":-14.820605,"median":-10.47753,"eighty":-7.976559,"marketCap":384382723},{"date":"2025-02-14","current":-5.254814,"twenty":-14.737372,"median":-10.453427,"eighty":-7.815984,"marketCap":335661764},{"date":"2025-02-21","current":-4.965779,"twenty":-14.726968,"median":-10.377826,"eighty":-7.723969,"marketCap":317199085},{"date":"2025-02-28","current":-5.134383,"twenty":-14.722286,"median":-10.300881,"eighty":-7.572086,"marketCap":327968981},{"date":"2025-03-07","current":-5.752596,"twenty":-14.70512,"median":-10.18045,"eighty":-7.459722,"marketCap":367458601},{"date":"2025-03-14","current":-5.978414,"twenty":-14.542126,"median":-10.060741,"eighty":-7.427006,"marketCap":437679710},{"date":"2025-03-21","current":-5.922279,"twenty":-14.497547,"median":-9.979906,"eighty":-7.330173,"marketCap":433570041},{"date":"2025-03-28","current":-5.869652,"twenty":-14.468597,"median":-9.843242,"eighty":-7.305561,"marketCap":429717227},{"date":"2025-04-04","current":-4.603098,"twenty":-14.357888,"median":-9.76419,"eighty":-7.260688,"marketCap":336992828},{"date":"2025-04-11","current":-4.245235,"twenty":-14.302548,"median":-9.646538,"eighty":-7.232265,"marketCap":310793690},{"date":"2025-04-17","current":-5.094283,"twenty":-14.285835,"median":-9.637837,"eighty":-7.153081,"marketCap":372952429},{"date":"2025-04-25","current":-6.076651,"twenty":-14.263987,"median":-9.604351,"eighty":-7.063704,"marketCap":444871630},{"date":"2025-05-02","current":-6.262368,"twenty":-14.234855,"median":-9.562236,"eighty":-6.926438,"marketCap":458467950},{"date":"2025-05-09","current":-4.879227,"twenty":-14.172431,"median":-9.534236,"eighty":-6.821271,"marketCap":404336659},{"date":"2025-05-16","current":-4.811029,"twenty":-14.114168,"median":-9.455187,"eighty":-6.61259,"marketCap":398685194},{"date":"2025-05-23","current":-4.733532,"twenty":-14.07379,"median":-9.435349,"eighty":-6.497664,"marketCap":392263074},{"date":"2025-05-30","current":-5.117918,"twenty":-14.057743,"median":-9.394303,"eighty":-6.409855,"marketCap":424116788},{"date":"2025-06-06","current":-5.855692,"twenty":-14.031834,"median":-9.322051,"eighty":-6.202372,"marketCap":485255368},{"date":"2025-06-13","current":-6.168781,"twenty":-13.987239,"median":-9.212186,"eighty":-6.076651,"marketCap":511200732},{"date":"2025-06-20","current":-5.217115,"twenty":-13.970758,"median":-9.168591,"eighty":-6.021603,"marketCap":432337101},{"date":"2025-06-27","current":-5.179916,"twenty":-13.942291,"median":-9.120655,"eighty":-5.974473,"marketCap":429254484},{"date":"2025-07-03","current":-5.090019,"twenty":-13.942291,"median":-9.040368,"eighty":-5.91924,"marketCap":421804825},{"date":"2025-07-11","current":-5.384509,"twenty":-13.936202,"median":-8.919862,"eighty":-5.881056,"marketCap":446208880},{"date":"2025-07-18","current":-5.765796,"twenty":-13.905046,"median":-8.775419,"eighty":-5.869652,"marketCap":477805709},{"date":"2025-07-25","current":-5.812294,"twenty":-13.868632,"median":-8.76039,"eighty":-5.846393,"marketCap":481658981},{"date":"2025-08-01","current":-6.860057,"twenty":-13.832218,"median":-8.727247,"eighty":-5.852592,"marketCap":568486040},{"date":"2025-08-08","current":-6.612066,"twenty":-13.785399,"median":-8.674924,"eighty":-5.855692,"marketCap":547935257},{"date":"2025-08-15","current":-6.50095,"twenty":-13.774995,"median":-8.602801,"eighty":-5.869652,"marketCap":575165044},{"date":"2025-08-22","current":-6.696472,"twenty":-13.765729,"median":-8.558717,"eighty":-5.871192,"marketCap":592463700},{"date":"2025-08-29","current":-6.687761,"twenty":-13.681359,"median":-8.364876,"eighty":-5.877392,"marketCap":591692932},{"date":"2025-09-05","current":-7.288875,"twenty":-13.66055,"median":-8.320014,"eighty":-5.87962,"marketCap":644875926},{"date":"2025-09-12","current":-13.857027,"twenty":-13.767582,"median":-8.344068,"eighty":-5.880428,"marketCap":1225986599},{"date":"2025-09-19","current":-13.883227,"twenty":-13.857027,"median":-8.528683,"eighty":-5.880943,"marketCap":1228304641},{"date":"2025-09-26","current":-13.891961,"twenty":-13.869253,"median":-8.595776,"eighty":-5.888044,"marketCap":1229077322},{"date":"2025-10-03","current":-13.935628,"twenty":-13.889631,"median":-8.662445,"eighty":-5.904554,"marketCap":1232940725},{"date":"2025-10-10","current":-13.953137,"twenty":-13.898365,"median":-8.723503,"eighty":-5.911052,"marketCap":1234489806},{"date":"2025-10-17","current":-13.967717,"twenty":-13.92573,"median":-8.755347,"eighty":-5.917743,"marketCap":1235779764},{"date":"2025-10-24","current":-13.985213,"twenty":-13.93742,"median":-8.766412,"eighty":-5.921671,"marketCap":1237327713},{"date":"2025-10-27","current":-13.991045,"twenty":-13.942291,"median":-8.76739,"eighty":-5.922279,"marketCap":1237843696}],"updateTime":1773750890719},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRML\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566933226","title":"Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range","url":"https://stock-news.laohu8.com/highlight/detail?id=2566933226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566933226?lang=en_us&edition=fundamental","pubTime":"2025-09-09 17:39","pubTimestamp":1757410740,"startTime":"0","endTime":"0","summary":"Novartis said it was buying a U.S.-listed biotech.Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what's been a flurry of acquisitions at a similar price point.Novartis said it was purchasing Tourmaline Bio for $48 per share, which had closed Monday at $30.18, valuing the New York company at $1.4 billion.Tourmaline shares  rocketed 56% to $47.10. Tourmaline has a drug in Phase 2 development to treat atherosclerotic cardiovascular disease, which Novartis calls a \"critical unmet need.\". According to FactSet, Novartis has bought several companies in the $1 billion to $3 billion range, including Regulus Therapeutics, Anthos Therapeutics, Kate Therapeutics, Mariana Oncology, MorphoSys, DTx Pharma and Chinook Therapeutics.Last month, the Financial Times reported Novartis was considering bidding for Avidity , a biotech developing treatments for rare muscle disorders.This content was created by MarketWatch, which is operated by Dow Jones & Co.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","BK4539","BK4578","RNA","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4588","IE0009355771.USD","BK4585","BK4007","LU0070302665.USD","IE00B4R5TH58.HKD","BK4139","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0208291251.USD","IE00B2B36J28.USD","LU0211331839.USD","BK4532","BK4505","TRML","NVS"],"gpt_icon":0},{"id":"1113528377","title":"Premarket Movers | Tourmaline Bio Soars 57%; Teck Resources Surges 8%; CoreWeave Jumps 7%; Alibaba Gains 3%; Planet Labs Sinks 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113528377","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113528377?lang=en_us&edition=fundamental","pubTime":"2025-09-09 16:25","pubTimestamp":1757406356,"startTime":"0","endTime":"0","summary":"Novartis will acquire $Tourmaline Bio(TRML)$ for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"43c9b39c5bc682e12986f02d017a3c05","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BABA","TECK","TRML","PL","CRWV","TRON"],"gpt_icon":0},{"id":"2566631506","title":"Swiss stocks - Factors to watch on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=2566631506","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566631506?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:16","pubTimestamp":1757395009,"startTime":"0","endTime":"0","summary":"Swiss stocks - Factors to watch on September 9 ZURICH/GDANSK, Sept 9 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday:NOVARTIS AG NOVN.SNovartis to acquire Tourmal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL5N3UW02L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382058.USD","LU0070302665.USD","LU1548497426.USD","LU2242649171.HKD","LU1244550494.USD","LU0320765646.SGD","TRML","LU0215105999.USD","LU0053666078.USD","LU0823434583.USD","BK4207","LU0640476718.USD","LU0942090050.USD","LU1551013342.USD","LU2023250843.SGD","LU0683600562.USD","IE00BDCRKT87.USD","LU0006306889.USD","BK4534","LU2592432038.USD","IE00BLSP4239.USD","LU2357305700.SGD","LU0882574139.USD","LU2505996681.GBP","LU0211326839.USD","LU1064131342.USD","LU1629891620.HKD","BK4550","LU2756315318.SGD","LU1244550221.USD","IE00BKVL7J92.USD","LU1267930490.SGD","IE0034235303.USD","LU1670628061.USD","LU0109394709.USD","LU0820561818.USD","LU2552382132.HKD","LU2237438978.USD","REGN","IE000M9KFDE8.USD","LU0964807845.USD","LU0496365809.HKD","LU1720051017.SGD","LU2237443895.HKD","LU0289739699.SGD","LU0345770993.USD","LU2023250504.SGD","LU0882574055.USD","LU2746668974.SGD","LU0823434740.USD"],"gpt_icon":0},{"id":"2566466369","title":"Novartis to Acquire Tourmaline Bio in Deal Valuing It at $1.4 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2566466369","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566466369?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:12","pubTimestamp":1757394765,"startTime":"0","endTime":"0","summary":"Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billionBERLIN, Sept 9  - Switzerland's Novartis NOVN.S will acquire Tourmaline Bio TRML.O with an offer price of $48 per share, in a deal valuing the New York-based company at $1.4 billion on a fully diluted basis, it said on Tuesday. Novartis said it expected the deal to close in the fourth quarter and for Tourmaline to become an indirect, wholly owned subsidiary.   ","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA4LFL2B:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novartis to Acquire Tourmaline Bio in Deal Valuing It at $1.4 Billion","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","NVS","BK4139","BK4539"],"gpt_icon":0},{"id":"2566636516","title":"BRIEF-Novartis To Buy Tourmaline Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2566636516","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566636516?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:05","pubTimestamp":1757394307,"startTime":"0","endTime":"0","summary":"BRIEF-Novartis To Buy Tourmaline BioSept 9 (Reuters) - NOVARTIS AG NOVN.S:TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOV","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL5N3UW02Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"2566663546","title":"Tourmaline Bio Inc - Novartis to Buy Tourmaline for $48 per Share, $1.4 Bln Equity Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2566663546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566663546?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:03","pubTimestamp":1757394184,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA2CTZZY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"2566635456","title":"Tourmaline Bio Enters Into Agreement to Be Acquired by Novartis Ag","url":"https://stock-news.laohu8.com/highlight/detail?id=2566635456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566635456?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:03","pubTimestamp":1757394184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA2CTZZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TRML","BK4139"],"gpt_icon":0},{"id":"2566635106","title":"Tourmaline Bio Inc - Deal Expected to Complete in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2566635106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566635106?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:03","pubTimestamp":1757394184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA2CTZZY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2566666357","title":"Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2566666357","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566666357?lang=en_us&edition=fundamental","pubTime":"2025-09-09 13:00","pubTimestamp":1757394000,"startTime":"0","endTime":"0","summary":"Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular diseasePacibekitug is a promising target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5fb54e106e0dea5e9f2c2ac0de52d562","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/09/3146558/0/en/Novartis-to-acquire-Tourmaline-Bio-complementing-cardiovascular-pipeline-with-pacibekitug-for-the-treatment-of-atherosclerotic-cardiovascular-disease-ASCVD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2563856252","title":"Tourmaline Bio Unveils Promising Phase 2 Trial Data for Pacibekitug at European Society of Cardiology Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2563856252","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563856252?lang=en_us&edition=fundamental","pubTime":"2025-08-31 22:24","pubTimestamp":1756650243,"startTime":"0","endTime":"0","summary":"Tourmaline Bio, Inc. , a late-stage clinical biotechnology company, has presented new data from its ongoing Phase 2 TRANQUILITY trial of pacibekitug at the European Society of Cardiology  Congress 2025 in Madrid, Spain. The presentation highlighted the drug's ability to consistently reduce high-sensitivity C-reactive protein  across a broad range of subgroups. Additionally, the study reported statistically significant reductions in secondary pharmacodynamic biomarkers associated with IL-6 pathway activity, including lipoprotein, fibrinogen, and serum amyloid A. The trial is a randomized, placebo-controlled study evaluating pacibekitug, a long-acting anti-IL-6 monoclonal antibody, in patients with elevated hs-CRP and chronic kidney disease. The results were previously summarized in a May 2025 press release by Tourmaline.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250831:nNDL2RzKCk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2563485625","title":"Tourmaline Bio Presents Data From the Ongoing Phase 2 Tranquility Trial at the 2025 European Society of Cardiology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2563485625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563485625?lang=en_us&edition=fundamental","pubTime":"2025-08-31 22:23","pubTimestamp":1756650230,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250831:nTUA9XJ22Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRML","BK4139","BK4539"],"gpt_icon":0},{"id":"2559966138","title":"Tourmaline Bio Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2559966138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559966138?lang=en_us&edition=fundamental","pubTime":"2025-08-15 00:25","pubTimestamp":1755188700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRML/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 14, 2025 12:25 ET (16:25 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0},{"id":"2559695658","title":"Wedbush Adjusts Price Target on Tourmaline Bio to $48 From $43, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2559695658","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559695658?lang=en_us&edition=fundamental","pubTime":"2025-08-14 18:15","pubTimestamp":1755166510,"startTime":"0","endTime":"0","summary":"Tourmaline Bio (TRML) has an average rating of buy and mean price target of $56.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRML"],"gpt_icon":0},{"id":"2559960167","title":"Tourmaline Bio Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559960167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559960167?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:33","pubTimestamp":1755084828,"startTime":"0","endTime":"0","summary":"Tourmaline Bio Inc reports results for the quarter ended June 30 - Earnings SummaryTourmaline Bio Inc TRML.OQ reported a quarterly adjusted loss of 90 cents per share for the quarter ended June 30, lo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL8N3U50P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0},{"id":"2559609601","title":"Tourmaline Bio Q2 EPS $(0.90) Beats $(0.94) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609601","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559609601?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:04","pubTimestamp":1755083046,"startTime":"0","endTime":"0","summary":"Tourmaline Bio Q2 EPS $(0.90) Beats $(0.94) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47085736/tourmaline-bio-q2-eps-0-90-beats-0-94-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0},{"id":"2559609668","title":"Tourmaline Bio : on Track to Initiate Phase 2 Proof-of-Concept Trial in Abdominal Aortic Aneurysm in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559609668?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:00","pubTimestamp":1755082801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA1XFQ0F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRML","BK4539","BK4139"],"gpt_icon":0},{"id":"2559609650","title":"Tourmaline Bio Inc:  Cash, Cash Equivalents, and Investments as of June 30 Provide Expected Cash Runway Into Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559609650?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:00","pubTimestamp":1755082801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA1XFQ0F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TRML","BK4139"],"gpt_icon":0},{"id":"2559609152","title":"Tourmaline Bio Inc: Qtrly Shr Loss $0.90","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559609152?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:00","pubTimestamp":1755082801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA1XFQ0F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TRML","BK4139"],"gpt_icon":0},{"id":"2559821602","title":"Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2559821602","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559821602?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:00","pubTimestamp":1755082800,"startTime":"0","endTime":"0","summary":"– Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132429/0/en/Tourmaline-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TRML","AAA","BK4139"],"gpt_icon":0},{"id":"2556382373","title":"Tourmaline Bio Inc  expected to post a loss of 94 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556382373","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556382373?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:26","pubTimestamp":1754314017,"startTime":"0","endTime":"0","summary":"Tourmaline Bio Inc  expected to post a loss of94cents a share - Earnings Preview Tourmaline Bio Inc TRML.OQ TRML.O is expected to  show no change in quarterly revenue when it reports  results on Augus","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRML"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":60,"code":"91000000","status":"200"}]}}